Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Amgen Inc and Onyx Pharmaceuticals Inc Announces Early Termination of HSR Waiting Period For Amgen's Acquisition of Onyx Pharmaceuticals


Wednesday, 18 Sep 2013 05:45pm EDT 

Amgen Inc and Onyx Pharmaceuticals Inc announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), in connection with Amgen's proposed acquisition of Onyx, was terminated early on September 18, 2013, by the United States Federal Trade Commission. The waiting period was scheduled to expire on September 23, 2013. 

Company Quote

153.26
-1.73 -1.12%
2 Jul 2015